首页> European urology> TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Stefan,Steurer

第一单位： Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

作者： Stefan,Steurer ^[1] ; Pascale Sophia,Mayer ^[1] ; Meike,Adam ^[2] ; Antje,Krohn ^[1] ; Christina,Koop ^[1] ; Daniel,Ospina-Klinck ^[1] ; Ali Attarchi,Tehrani ^[1] ; Ronald,Simon ^[1] ; Pierre,Tennstedt ^[2] ; Markus,Graefen ^[2] ; Corinna,Wittmer ^[1] ; Benedikt,Brors ^[3] ; Christoph,Plass ^[4] ; Jan,Korbel ^[5] ; Joachim,Weischenfeldt ^[5] ; Guido,Sauter ^[1] ; Hartwig,Huland ^[2] ; Maria Christina,Tsourlakis ^[1] ; Sarah,Minner ^[1] ; Thorsten,Schlomm ^[6]

作者单位： Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[1] Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[2] Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany. ^[3] Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany. ^[4] Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. ^[5] Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: tschlomm@uke.de. ^[6]

关键词 5q 6q Age Deletion ERG Early onset Gene fusion Molecular PTEN Prognosis Prostate cancer Subtype TMPRSS-ERG